Tower Trust & Investment CO Exact Sciences Corp Transaction History
Tower Trust & Investment CO
- $124 Billion
- Q1 2025
A detailed history of Tower Trust & Investment CO transactions in Exact Sciences Corp stock. As of the latest transaction made, Tower Trust & Investment CO holds 900 shares of EXAS stock, worth $48,060. This represents 0.03% of its overall portfolio holdings.
Number of Shares
900Holding current value
$48,060% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
666Shares Held
162MCall Options Held
4.22MPut Options Held
1.93M-
Capital World Investors Los Angeles, CA17.8MShares$952 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$942 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$668 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$644 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.4MShares$342 Million0.03% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.45B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...